Cargando…
Role of Non-Coding RNAs in the Development of Targeted Therapy and Immunotherapy Approaches for Chronic Lymphocytic Leukemia
In the past decade, novel targeted therapy approaches, such as BTK inhibitors and Bcl2 blockers, and innovative treatments that regulate the immune response against cancer cells, such as monoclonal antibodies, CAR-T cell therapy, and immunomodulatory molecules, have been established to provide suppo...
Autores principales: | Pepe, Felice, Balatti, Veronica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074107/ https://www.ncbi.nlm.nih.gov/pubmed/32098192 http://dx.doi.org/10.3390/jcm9020593 |
Ejemplares similares
-
Small Non-Coding RNAs in Leukemia
por: Balatti, Veronica, et al.
Publicado: (2022) -
Role of microRNA in chronic lymphocytic leukemia onset and progression
por: Balatti, Veronica, et al.
Publicado: (2015) -
Non-Coding RNAs as Cancer Hallmarks in Chronic Lymphocytic Leukemia
por: Fabris, Linda, et al.
Publicado: (2020) -
MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia
por: Visone, Rosa, et al.
Publicado: (2012) -
Role of long non-coding RNAs in disease progression of early stage unmutated chronic lymphocytic leukemia
por: Tschumper, Renee C., et al.
Publicado: (2019)